For more information, please visit lek.com/covid19 or fill out this form to get in touch. Other editions in this series:European Disease progression monitor: Edition III Related Practice Life Sciences & Pharma Italy, Spain and France are now several weeks past peak virus intensity, taking approximately two weeks to reach 50% of peak levels 01262022170116
For more information, please visit lek.com/covid19 or fill out this form to get in touch. Other editions in this series:European Disease progression monitor: Edition III
Article Life Sciences & Pharma Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors July 2, 2024
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Executive Insights Diagnostics, Tools and Personalized Medicine Commercial Excellence in Life Sciences Tools and Services Companies April 8, 2024
Executive Insights Organization & Performance Disruptive Trends in Corporate Transformation: Converting Ideas Into Action August 23, 2023